The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism*; D002478:Cells, Cultured; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D004347:Drug Interactions; D004686:Encephalomyocarditis virus / Q000187:drug effects; D005910:Glioma / Q000378:metabolism / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000378:metabolism / Q000628:therapy; D009843:Oligoribonucleotides / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology
D000227:Adenine Nucleotides; D007370:Interferon Type I; D009843:Oligoribonucleotides; D011994:Recombinant Proteins; C023505:2',5'-oligoadenylate; D007371:Interferon-gamma; D015088:2',5'-Oligoadenylate Synthetase